Sunbelt Securities’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.79M Buy
40,395
+3
+0% +$665 0.55% 34
2025
Q4
$9.23M Sell
40,392
-182
-0.4% -$41.5K 0.62% 29
2025
Q3
$9.39M Sell
40,574
-5,921
-13% -$1.21M 0.65% 27
2025
Q2
$8.26M Buy
46,495
+6,013
+15% +$1.12M 0.73% 21
2025
Q1
$8.48M Sell
40,482
-6,013
-13% -$1.17M 0.76% 20
2024
Q4
$8.19M Sell
46,495
-116
-0.2% -$21.3K 0.72% 21
2024
Q3
$9.2M Sell
46,611
-1,409
-3% -$263K 0.9% 14
2024
Q2
$8.24M Buy
48,020
+1,622
+3% +$269K 0.84% 20
2024
Q1
$8.45M Sell
46,398
-4,204
-8% -$725K 0.94% 16
2023
Q4
$7.84M Sell
50,602
-864
-2% -$126K 0.99% 14
2023
Q3
$7.67M Buy
51,466
+10,277
+25% +$1.51M 1.06% 13
2023
Q2
$5.55M Sell
41,189
-2,346
-5% -$344K 0.8% 22
2023
Q1
$6.87M Buy
43,535
+3,493
+9% +$534K 1.11% 13
2022
Q4
$6.47M Buy
40,042
+213
+0.5% +$32.7K 1.26% 11
2022
Q3
$5.34M Buy
39,829
+1,156
+3% +$166K 1.13% 13
2022
Q2
$5.92M Sell
38,673
-1,549
-4% -$237K 1.25% 12
2022
Q1
$6.59M Sell
40,222
-26,131
-39% -$3.8M 1.21% 13
2021
Q4
$9.52M Sell
66,353
-4,795
-7% -$566K 1.55% 8
2021
Q3
$8.36M Hold
71,148
1.5% 9
2021
Q2
$8.36M Sell
71,148
-263
-0.4% -$29.6K 1.5% 9
2021
Q1
$7.73M Sell
71,411
-10,271
-13% -$1.1M 1.52% 6
2020
Q4
$8.75M Sell
81,682
-5,496
-6% -$528K 1.81% 7
2020
Q3
$8.1M Buy
87,178
+43,807
+101% +$4.12M 2.25% 5
2020
Q2
$4.26M Buy
43,371
+1,203
+3% +$106K 1.46% 10
2020
Q1
$3.21M Sell
42,168
-64,137
-60% -$5.46M 0.14% 75
2019
Q4
$9.41M Buy
106,305
+4,175
+4% +$347K 0.99% 18
2019
Q3
$7.73M Buy
102,130
+65,293
+177% +$4.48M 0.87% 20
2019
Q2
$2.68M Buy
36,837
+702
+2% +$55.2K 1.17% 16
2019
Q1
$2.91M Buy
36,135
+131
+0.4% +$10.7K 1.46% 13
2018
Q4
$3.32M Buy
36,004
+1,224
+4% +$108K 1.93% 7
2018
Q3
$3.29M Sell
34,780
-2,800
-7% -$266K 1.76% 8
2018
Q2
$3.48M Buy
37,580
+21,824
+139% +$2.13M 2.08% 5
2018
Q1
$1.49M Sell
15,756
-660
-4% -$72.5K 1.36% 15
2017
Q4
$1.59M Buy
16,416
+936
+6% +$88.2K 1.54% 9
2017
Q3
$1.38M Buy
15,480
+12,614
+440% +$960K 1.45% 10
2017
Q2
$208K Sell
2,866
-378
-12% -$25.4K 0.39% 73
2017
Q1
$211K Hold
3,244
0.32% 84
2016
Q4
$203K Sell
3,244
-120
-4% -$7.33K 0.31% 85
2016
Q3
$212K Hold
3,364
0.26% 94
2016
Q2
$208K Sell
3,364
-175
-5% -$10.7K 0.27% 90
2016
Q1
$202K Hold
3,539
0.29% 84
2015
Q4
$210K Buy
+3,539
New +$204K 0.3% 79
2015
Q3
Sell
-3,609
Closed -$242K 114
2015
Q2
$242K Buy
3,609
+164
+5% +$10.7K 0.33% 76
2015
Q1
$202K Sell
3,445
-800
-19% -$48.3K 0.3% 92
2014
Q4
$278K Buy
+4,245
New +$268K 0.37% 60

Other funds holding ABBV

Sunbelt Securities's ABBV Position: Q1 2026 in Review

Sunbelt Securities increased its AbbVie (ABBV) stake by 0.01% in Q1 2026, buying an estimated $665 and bringing the position to 40,395 shares worth $8.79M. The position accounts for 0.55% of the portfolio, ranked #34.

Sunbelt Securities first reported a position in ABBV in Q4 2014 and has held it in 45 quarters since. The position peaked at $9.52M in Q4 2021. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Sunbelt Securities held 40,395 shares of AbbVie worth $8.79M as of Q1 2026.
  • Sunbelt Securities bought 3 AbbVie shares in Q1 2026, an estimated $665.
  • AbbVie made up 0.55% of Sunbelt Securities's portfolio in Q1 2026, its #34 holding.
  • Sunbelt Securities first reported a position in AbbVie in Q4 2014 and has held it in 45 quarters since.
  • Sunbelt Securities's AbbVie position peaked at $9.52M in Q4 2021.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.